Barclays’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,500
| Closed | -$83K | – | 5218 |
|
|
2020
Q3 | $83K | Hold |
6,500
| – | – | ﹤0.01% | 4348 |
|
|
2020
Q2 | $71K | Sell |
6,500
-400
| -6% | -$4.14K | ﹤0.01% | 4744 |
|
|
2020
Q1 | $72K | Sell |
6,900
-300
| -4% | -$3.87K | ﹤0.01% | 5003 |
|
|
2019
Q4 | $116K | Buy |
7,200
+1,500
| +26% | +$24.8K | ﹤0.01% | 5398 |
|
|
2019
Q3 | $89K | Buy |
+5,700
| New | +$94.8K | ﹤0.01% | 5565 |
|
|
2018
Q2 | – | Sell |
-8,300
| Closed | -$113K | – | 7384 |
|
|
2018
Q1 | $113K | Buy |
8,300
+6,500
| +361% | +$85.6K | ﹤0.01% | 5301 |
|
|
2017
Q4 | $24K | Buy |
1,800
+1,200
| +200% | +$17.2K | ﹤0.01% | 6218 |
|
|
2017
Q3 | $9K | Buy |
600
+100
| +20% | +$1.61K | ﹤0.01% | 6201 |
|
|
2017
Q2 | $9K | Sell |
500
-38,200
| -99% | -$581K | ﹤0.01% | 6096 |
|
|
2017
Q1 | $590K | Sell |
38,700
-300
| -0.8% | -$4.42K | ﹤0.01% | 3241 |
|
|
2016
Q4 | $513K | Buy |
39,000
+37,500
| +2,500% | +$480K | ﹤0.01% | 3347 |
|
|
2016
Q3 | $17K | Buy |
1,500
+800
| +114% | +$9.61K | ﹤0.01% | 5562 |
|
|
2016
Q2 | $8K | Buy |
700
+300
| +75% | +$4.03K | ﹤0.01% | 5625 |
|
|
2016
Q1 | $6K | Sell |
400
-2,700
| -87% | -$41K | ﹤0.01% | 5639 |
|
|
2015
Q4 | $50K | Buy |
3,100
+1,300
| +72% | +$19K | ﹤0.01% | 4794 |
|
|
2015
Q3 | $22K | Sell |
1,800
-100
| -5% | -$1.37K | ﹤0.01% | 5423 |
|
|
2015
Q2 | $30K | Sell |
1,900
-3,800
| -67% | -$61.2K | ﹤0.01% | 5450 |
|
|
2015
Q1 | $86K | Buy |
5,700
+600
| +12% | +$9.92K | ﹤0.01% | 4952 |
|
|
2014
Q4 | $77K | Buy |
5,100
+2,500
| +96% | +$36.5K | ﹤0.01% | 5397 |
|
|
2014
Q3 | $34K | Buy |
2,600
+2,200
| +550% | +$33.4K | ﹤0.01% | 6160 |
|
|
2014
Q2 | $6K | Sell |
400
-11,900
| -97% | -$188K | ﹤0.01% | 7079 |
|
|
2014
Q1 | $197K | Buy |
12,300
+11,000
| +846% | +$199K | ﹤0.01% | 4809 |
|
|
2013
Q4 | $27K | Sell |
1,300
-4,200
| -76% | -$94.6K | ﹤0.01% | 6552 |
|
|
2013
Q3 | $116K | Sell |
5,500
-2,700
| -33% | -$57.6K | ﹤0.01% | 5501 |
|
|
2013
Q2 | $153K | Buy |
+8,200
| New | +$150K | ﹤0.01% | 5435 |
|
Other funds holding NXGN
Barclays's NXGN Position: Q4 2023 in Review
Barclays sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 87,444 shares — an estimated $2.08M sold.
Barclays first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $5.28M in Q3 2013. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Barclays reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Barclays sold 87,444 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $2.08M.
- Barclays first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Barclays's NextGen Healthcare, Inc. Common Stock position peaked at $5.28M in Q3 2013.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.